Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2

por Fedier, A, Ruefenacht, U B, Schwarz, V A, Haller, U, Fink, D
Publicado 2002

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells

por Schwarz, V A, Hornung, R, Fedier, A, Fehr, M K, Walt, H, Haller, U, Fink, D
Publicado 2002

The glycosphingolipid P(1) is an ovarian cancer-associated carbohydrate antigen involved in migration

por Jacob, F, Anugraham, M, Pochechueva, T, Tse, B W C, Alam, S, Guertler, R, Bovin, N V, Fedier, A, Hacker, N F, Huflejt, M E, Packer, N, Heinzelmann-Schwarz, V A
Publicado 2014

A distinct molecular profile associated with mucinous epithelial ovarian cancer

por Heinzelmann-Schwarz, V A, Gardiner-Garden, M, Henshall, S M, Scurry, J P, Scolyer, R A, Smith, A N, Bali, A, Bergh, P Vanden, Baron-Hay, S, Scott, C, Fink, D, Hacker, N F, Sutherland, R L, O'Brien, P M
Publicado 2006

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, D I, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

por O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Murali, R, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, Di, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L
Publicado 2008